3-(2,2,2-trimethylhydrazine)propionate has been researched along with acetylcysteine in 1 studies
Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (acetylcysteine) | Trials (acetylcysteine) | Recent Studies (post-2010) (acetylcysteine) |
---|---|---|---|---|---|
251 | 35 | 105 | 14,580 | 1,046 | 5,960 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bohle, DS; Coderre, TJ; Fulas, OA; Laferriere, A; Stein, RS | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and acetylcysteine
Article | Year |
---|---|
Topical combination of meldonium and N-acetyl cysteine relieves allodynia in rat models of CRPS-1 and peripheral neuropathic pain by enhancing NO-mediated tissue oxygenation.
Topics: Acetylcysteine; Administration, Topical; Animals; Disease Models, Animal; Hyperalgesia; Male; Methylhydrazines; Neuralgia; Nitric Oxide; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reflex Sympathetic Dystrophy | 2020 |